Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference129 articles.
1. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases;Abrey;J. Neurooncol.,2001
2. Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases;Ahmed;J. Neurooncol.,2017
3. Arnold A and Ellis PM survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases;Ali;Curr. Oncol.,2013
4. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial;Andrews;Lancet,2004
5. Phase 1/2 study of the safety and clinical activity of durvalumab in patients with non-small cell lung cancer (NSCLC);Antonia;Ann. Oncol.,2016
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A predictive model based on liquid biopsy for non-small cell lung cancer to assess patient’s prognosis: Development and application;Tissue and Cell;2022-08
2. Targeted therapy of brain metastases in patients with ALK-positive non-small cell lung cancer: A review;Journal of Modern Oncology;2021-12-15
3. The number of brain metastases predicts the survival of non‐small cell lung cancer patients with EGFR mutation status;Cancer Reports;2021-11-12
4. Rational application of gefitinib in NSCLC patients with sensitive EGFR mutations based on pharmacokinetics and metabolomics;Acta Pharmacologica Sinica;2021-11-04
5. Immune checkpoint inhibitors plus anlotinib versus anlotinib alone as third-line treatment in advanced non-small-cell lung cancer: a retrospective study;Future Oncology;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3